drugset / Trial / NCT06088784
A Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety, tolerability and pharmacokinetics of single and multiple doses of ATH-399A in healthy adults and also evaluate the effect of food on ATH-399A in order to develop mechanism-based and/or disease-modifying treatments for Parkinson Disease.
Timeline
- Start
- 2023-09-19
- Primary completion
- 2024-04-24
- Completion
- 2024-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATH-399A | Unknown | 5 mg | Oral |
| Subject | ATH-399A | Unknown | 10 mg | Oral |
| Subject | ATH-399A | Unknown | 20 mg | Oral |
| Subject | ATH-399A | Unknown | 40 mg | Oral |
| Subject | ATH-399A | Unknown | 80 mg | Oral |
Indications
No indication recorded.